Alan P. Johnson
Antibiotic Resistance Monitoring and Reference Laboratory
Central Public Health Laboratory
Colindale
London NW9 5HT
UK
Name/email consistency: high
- In vitro activity of cephalosporin RWJ-54428 (MC-02479) against multidrug-resistant gram-positive cocci. Johnson, A.P., Warner, M., Carter, M., Livermore, D.M. Antimicrob. Agents Chemother. (2002)
- Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales. Johnson, A.P., Warner, M., George, R.C., Livermore, D.M. J. Antimicrob. Chemother. (2001)
- Activity of moxifloxacin and other quinolones against pneumococci resistant to first-line agents, or with high-level ciprofloxacin resistance. Johnson, A.P., Warner, M., Livermore, D.M. Int. J. Antimicrob. Agents (2001)
- Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK. Johnson, A.P., Henwood, C.J., Tysall, L., Warner, M. Int. J. Antimicrob. Agents (2001)
- Anti-MRSA cephalosporins Bristol-Myers Squibb. Johnson, A.P. Curr. Opin. Investig. Drugs (2001)
- Telithromycin. Aventis Pharma. Johnson, A.P. Curr. Opin. Investig. Drugs (2001)
- Antimicrobial susceptibility of Gram-positive bacteria: what's current, what's anticipated?. Johnson, A.P., Livermore, D.M., Tillotson, G.S. J. Hosp. Infect. (2001)
- Activity of linezolid against multi-resistant gram-positive bacteria from diverse hospitals in the United Kingdom. Johnson, A.P., Warner, M., Livermore, D.M. J. Antimicrob. Chemother. (2000)
- Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999. Johnson, A.P., Warner, M., Hallas, G., Livermore, D.M. J. Antimicrob. Chemother. (2000)
- Pazufloxacin Toyama Chemical Co. Johnson, A.P. Curr. Opin. Investig. Drugs (2000)